22
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A novel nomogram for the preoperative prediction of sentinel lymph node metastasis in breast cancer

      research-article

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background or Purpose

          A practical noninvasive method to identify sentinel lymph node (SLN) status in breast cancer patients, who had a suspicious axillary lymph node (ALN) at ultrasound (US), but a negative clinical physical examination is needed. To predict SLN metastasis using a nomogram based on US and biopsy‐based pathological features, this retrospective study investigated associations between clinicopathological features and SLN status.

          Methods

          Patients treated with SLN dissection at four centers were apportioned to training, internal, or external validation sets ( n = 472, 175, and 81). Lymph node ultrasound and pathological characteristics were compared using chi‐squared and t‐tests. A nomogram predicting SLN metastasis was constructed using multivariate logistic regression models.

          Results

          In the training set, statistically significant factors associated with SLN + were as follows: histology type ( p < 0.001); progesterone receptor (PR: p = 0.003); Her‐2 status ( p = 0.049); and ALN‐US shape ( p = 0.034), corticomedullary demarcation (CMD: p < 0.001), and blood flow ( p = 0.001). With multivariate analysis, five independent variables (histological type, PR status, ALN‐US shape, CMD, and blood flow) were integrated into the nomogram (C‐statistic 0.714 [95% CI: 0.688–0.740]) and validated internally (0.816 [95% CI: 0.784–0.849]) and externally (0.942 [95% CI: 0.918–0.966]), with good predictive accuracy and clinical applicability.

          Conclusion

          This nomogram could be a direct and reliable tool for individual preoperative evaluation of SLN status, and therefore aids decisions concerning ALN dissection and adjuvant treatment.

          Abstract

          This nomogram is using pathology and ultrasound parameters preoperatively to predict SLN metastasis. Cindex, calibration, discrimination, and clinical use of the nomogram show well in the training, internal and external validation sets.

          Related collections

          Most cited references47

          • Record: found
          • Abstract: found
          • Article: not found

          Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

          This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across 20 world regions. There will be an estimated 18.1 million new cancer cases (17.0 million excluding nonmelanoma skin cancer) and 9.6 million cancer deaths (9.5 million excluding nonmelanoma skin cancer) in 2018. In both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of cancer death (18.4% of the total cancer deaths), closely followed by female breast cancer (11.6%), prostate cancer (7.1%), and colorectal cancer (6.1%) for incidence and colorectal cancer (9.2%), stomach cancer (8.2%), and liver cancer (8.2%) for mortality. Lung cancer is the most frequent cancer and the leading cause of cancer death among males, followed by prostate and colorectal cancer (for incidence) and liver and stomach cancer (for mortality). Among females, breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death, followed by colorectal and lung cancer (for incidence), and vice versa (for mortality); cervical cancer ranks fourth for both incidence and mortality. The most frequently diagnosed cancer and the leading cause of cancer death, however, substantially vary across countries and within each country depending on the degree of economic development and associated social and life style factors. It is noteworthy that high-quality cancer registry data, the basis for planning and implementing evidence-based cancer control programs, are not available in most low- and middle-income countries. The Global Initiative for Cancer Registry Development is an international partnership that supports better estimation, as well as the collection and use of local data, to prioritize and evaluate national cancer control efforts. CA: A Cancer Journal for Clinicians 2018;0:1-31. © 2018 American Cancer Society.
            • Record: found
            • Abstract: found
            • Article: not found

            Cancer statistics in China, 2015.

            With increasing incidence and mortality, cancer is the leading cause of death in China and is a major public health problem. Because of China's massive population (1.37 billion), previous national incidence and mortality estimates have been limited to small samples of the population using data from the 1990s or based on a specific year. With high-quality data from an additional number of population-based registries now available through the National Central Cancer Registry of China, the authors analyzed data from 72 local, population-based cancer registries (2009-2011), representing 6.5% of the population, to estimate the number of new cases and cancer deaths for 2015. Data from 22 registries were used for trend analyses (2000-2011). The results indicated that an estimated 4292,000 new cancer cases and 2814,000 cancer deaths would occur in China in 2015, with lung cancer being the most common incident cancer and the leading cause of cancer death. Stomach, esophageal, and liver cancers were also commonly diagnosed and were identified as leading causes of cancer death. Residents of rural areas had significantly higher age-standardized (Segi population) incidence and mortality rates for all cancers combined than urban residents (213.6 per 100,000 vs 191.5 per 100,000 for incidence; 149.0 per 100,000 vs 109.5 per 100,000 for mortality, respectively). For all cancers combined, the incidence rates were stable during 2000 through 2011 for males (+0.2% per year; P = .1), whereas they increased significantly (+2.2% per year; P < .05) among females. In contrast, the mortality rates since 2006 have decreased significantly for both males (-1.4% per year; P < .05) and females (-1.1% per year; P < .05). Many of the estimated cancer cases and deaths can be prevented through reducing the prevalence of risk factors, while increasing the effectiveness of clinical care delivery, particularly for those living in rural areas and in disadvantaged populations.
              • Record: found
              • Abstract: found
              • Article: not found

              Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer.

              To develop and validate a radiomics nomogram for preoperative prediction of lymph node (LN) metastasis in patients with colorectal cancer (CRC).

                Author and article information

                Contributors
                sunqiangpumc2020@sina.com
                Journal
                Cancer Med
                Cancer Med
                10.1002/(ISSN)2045-7634
                CAM4
                Cancer Medicine
                John Wiley and Sons Inc. (Hoboken )
                2045-7634
                15 December 2022
                March 2023
                : 12
                : 6 ( doiID: 10.1002/cam4.v12.6 )
                : 7039-7050
                Affiliations
                [ 1 ] Breast Surgery Department, Chinese Academy of Medical Sciences and Peking Union Medical College Peking Union Medical College and Hospital Beijing China
                [ 2 ] Department of Thoracic Surgery National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China
                [ 3 ] Radiology Department, Xiangtan Central Hospital Hunan China
                [ 4 ] Ultrasound Medicine Department Chinese Academy of Medical Sciences and Peking Union Medical College, Peking Union Medical College Hospital Beijing China
                [ 5 ] Molecular Pathology Research Center, Department of Pathology Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing China
                [ 6 ] Breast Surgery Department Baoji Maternal and Child Health Hospital Shaanxi China
                [ 7 ] Breast Surgery Department Qinghai Provincial People's Hospital Qinghai China
                [ 8 ] Breast Surgery Department Shanxi Traditional Chinese Medical Hospital Shanxi China
                Author notes
                [*] [* ] Correspondence

                Qiang Sun, Breast Surgery Department, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 3 Dongdan, Dongcheng District, Beijing, China.

                Email: sunqiangpumc2020@ 123456sina.com

                Author information
                https://orcid.org/0000-0002-9516-4598
                Article
                CAM45503 CAM4-2022-03-1291.R1
                10.1002/cam4.5503
                10067027
                36524283
                6e751a88-faff-4604-9be6-e0d410516cbb
                © 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 29 October 2022
                : 29 March 2022
                : 22 November 2022
                Page count
                Figures: 4, Tables: 2, Pages: 12, Words: 6570
                Funding
                Funded by: CAMS Innovation Fund for Medical Sciences (CIFMS)
                Award ID: 2021‐I2M‐C&T‐B‐018
                Funded by: Fundamental Research Funds for the Central Universities , doi 10.13039/501100012226;
                Award ID: 3332021012
                Funded by: National High Level Hospital Clinical Research Funding
                Award ID: 2022‐PUMCH‐A‐018
                Funded by: Tsinghua University‐Peking Union Medical College Hospital Initiative Scientific Research Program
                Award ID: 2019Z
                Categories
                Research Article
                RESEARCH ARTICLES
                Clinical Cancer Research
                Custom metadata
                2.0
                March 2023
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.7 mode:remove_FC converted:02.04.2023

                Oncology & Radiotherapy
                axillary lymph node (aln),breast cancer,nomogram,sentinel lymph node (sln),ultrasound

                Comments

                Comment on this article

                Related Documents Log